Cyclotron-based Radiopharmaceuticals to be produced in Sri Lanka
- 5opn1
- November 9, 2024
- News
- Cyclotron-based, Radiopharmaceuticals, Sri Lanka
- 0 Comments
Access Medical Tracers (Private) Limited, a special purpose vehicle majority owned by Access Engineering Plc, has won the bid to build, operate and own (BOO) a cyclotron based radiopharmaceutical production facility in Sri Lanka, the company said.
“This is the first time such a facility is developed in the Country to produce Fluoro – Deoxy-Glucose (FDG) which is required mainly for the purpose of cancer detection,” Access Engineering said in a stock exchange filing.
The development cost of the production facility is estimated at 6.5 million dollars. The investment amount of Access Engineering will be notified in due course, the company said.
The ground breaking ceremony for the facility was held on Friday (8). Following a competitive bidding process a BOO agreement was signed on Tuesday (5) between Sri Lanka Atomic Energy Board, the Ministry of Health and Access Medical Tracers (Private) Limited (special purpose vehicle) for the implementation of the production facility.
